Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Samba O. Sow et al.|The Lancet Infectious Diseases|2020Cited by 76
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trialMilagritos D. Tapia, Abena Kunadu Yawson, Samba O. Sow et al.|The Lancet Infectious Diseases|2020Cited by 65
Track C Epidemiology and Prevention ScienceDana N. Raugi, Yuhua Ruan, Fousseyni Traoré et al.|Journal of the International AIDS Society|2012Cited by 0